Ketamine One becomes exclusive provider of ketamine treatment to Victoria Wellness

KetamineOne Capital announced that it has entered into a one-year agreement with Victoria Wellness Mental Health Residential and Addiction Treatment Centre (VW) to be its exclusive ketamine treatment provider.

The Vancouver, British Columbia-based company said it and the centre have launched a first-class, best practice-based, six-week inpatient Ketamine Integrated Therapy Experience (KITE) program. 

The first three weeks of the KITE program is being structured to offer clients a unique opportunity to benefit from fast-acting, evidence-based and medically supervised ketamine administration to help combat long-standing and prescription resistant mental health conditions such as depression and post-traumatic stress disorder (PTSD), the company added. 

READ: KetamineOne Capital says its common shares have been successfully uplisted to the OTCQB

“This exclusive agreement with VW is a meaningful opportunity to help even more veterans and other members of the general public who are battling daily with anxiety, depression and PTSD,” Ketamine One (NEO:MEDI.AQN) chief operating offer Steven Inglefield said in a statement. 

“Growing our network of clinics, both directly and indirectly such as through this agreement, is a core part of the company’s competitive strategy. We are working hard to expand our operations and, ultimately, what that means is working hard to help more people,” he added.

Ketamine One (NEO:MEDI.AQN) noted that Gores Landing, Ontario-based VW is a residential rehabilitation facility and mental clinic focused on treating anxiety, depression and PTSD by offering personalized therapy treatment programs with a connection to nature to both veterans and the general public. By incorporating ketamine-assisted psychotherapy into its service offering it aims to become a leader in the mental health industry. 

Under the program, Ketamine One (NEO:MEDI.AQN) said doses of ketamine will be supplemented with specialized and integrated ketamine-assisted psychotherapy. The KITE program will also see VW’s clients embark on a comprehensive, premium, six-week residential recovery experience featuring the best in both data-driven recovery therapies and holistic healing traditions.

Based on Ketamine One’s previously announced partnership, clients will be triaged and psychologically assessed by iHealthOX. Those deemed appropriate for treatment will receive ketamine intravenously at an off-site, third-party pain centre.

“This partnership allows us to provide inpatient residential care with ketamine to the veterans, military and first responders who are suffering from PTSD, depression and other mental health issues,” VW executive director Joe Ann Kortman said. “From my own personal experience, you can get better and our KITE program is designed to help you fly.”

Additionally, Ketamine One reported that data collection from the first participants in its previously announced single-arm, open-label study of patients with PTSD who are undergoing the proprietary physical therapy program at its IRP Health clinics began on January 4, 2022. 

The company also announced that the re-branding of IRP Health is now complete. Interested parties can visit www.irphealth.ca to experience the new brand, it said.

KetamineOne Capital is focused on consolidating medical clinics and becoming a North American leader in mental health treatments. It is working to provide the critical infrastructure needed to develop and deliver breakthrough mental health treatments. Currently, Ketamine One has a network of clinics across North America, with plans to further consolidate the highly fragmented industry.

KGK Science Inc. is the company’s wholly-owned contract research division, which places it at the forefront of premium clinical research based on the subsidiary’s history and extensive experience in pharmaceuticals, cannabis, and the emerging psychedelic medicine industries. 

Contact the author at [email protected]

Story by ProactiveInvestors